Shou-Jiang (SJ) Gao
Academic Editor

Shou-Jiang (SJ) Gao


Dr. Gao is a Professor in the Department of Molecular Microbiology and Immunology, USC Keck School of Medicine. He is a member of the USC Institute for Emerging Pathogens and Immune Diseases and a member of the USC Norris Comprehensive Cancer center. Dr. Gao participates in the Programs in Biomedical and Biological Sciences (PIBBS) and in the Ph.D. Program in Medical Biology (MEDB).

Dr. Gao is an Elected Fellow of the American Academy of Microbiology. He currently serves as the Editor-In-Chief for the Journal of Medical Virology, Section Editor for PLoS Pathogens, and Academic Editor for PLoS One and PeerJ. He is also serving on the Editorial Boards of over 10 peer-reviewed journals including Journal of Virology, Journal of Antivirals & Antiretrovirals, Journal of Molecular Biomarkers and Diagnosis, Journal of Microbial & Biochemical Technology, Sarcoma Research International, Oncolytic Virotherapy, etc.

Cell Biology HIV Infectious Diseases Oncology Virology

Work details

Professor of Molecular Microbiology & Immunology

Keck School of Medicine
Department of Molecular Microbiology and Immunology
Dr. Gao’s laboratory is interested in the biology of infection and oncogenesis of tumor viruses. The current focus is on Kaposi’s sarcoma-associated herpesvirus (KSHV) and its associated cancers. Viral infection is the cause of up to 15% of human cancers. As examples, human papilloma virus (HPV) infection is associated with cervical carcinoma while hepatitis C virus (HCV) or hepatitis B virus (HBV) infection is associated with hepatocellular carcinoma. KSHV infection is causally linked to the development of Kaposi’s sarcoma (KS), primary effusion lymphoma (PEL), and a subset of multicentric Castleman’s disease (MCD). KS is a highly inflammatory and vascularized spindle cell cancer of proliferative endothelial cells commonly found in AIDS patients. In some African regions, KS has become the most common cancer in patients with and without HIV infection. As an important emerging human pathogen, KSHV is an excellent model for studying inflammation, angiogenesis, oncogenesis, and virus-host and virus-virus interactions. The lab employs comprehensive genetic, genomic, molecular, cellular, and biochemical approaches to address these complex problems.

PeerJ Contributions